fashion -WSS

fashion

author：fashion 2025-09-30 22:07:53 - browse：67

A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT — Adobe

The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Amazon on where the company's health care bets are headed next

WSS

The 10 drugs up first for Medicare price negotiation

Report cites 'urgent' need to recruit more diverse clinical trial participants

Report cites 'urgent' need to recruit more diverse clinical trial participants

Resistance to opioid

A new House health package & hospitals’ new site

Abbott's new heart device gets FDA advisory panel nod

knowledge

fashion

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

House transparency, PBM reform bill gains bipartisan support

BioMarin wins approval for gene therapy to treat hemophilia A

Report cites 'urgent' need to recruit more diverse clinical trial participants

As demand for Covid shots wanes, Moderna seeks its next success

Covid hospitalizations on the rise, Humana says

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

explore

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

The (many) problems with a new study criticizing cancer screening

Bernie Sanders gets little from pharma CEOs on drug prices

Amazon on where the company's health care bets are headed next

House transparency, PBM reform bill gains bipartisan support

What American doctors can learn from their Israeli counterparts

Wikipedia

hotspot

focus

explore